Navigation Links
University Participating in West Nile Vaccine Trial

Vanderbilt University Medical Center researchers, in collaboration with investigators at Johns Hopkins University, are beginning a Phase I trial to test// a new vaccine against the West Nile virus.

The mosquito-borne virus, which can cause serious illness, is making its yearly appearance in Middle Tennessee. While no human cases of West Nile have been reported in the state so far this season, mosquitoes collected from around Nashville have tested positive for the virus.

"When West Nile virus first appeared in the United States five or six years ago, it spread remarkably quickly across the country," said Peter Wright, M.D., professor of Pediatrics, Microbiology and Immunology, and Pathology, who is heading up Vanderbilt's efforts in the trial. "There's no part of the country that has not experienced human and bird cases of West Nile."

Although around 80 percent of people infected by West Nile virus show no symptoms, up to 20 percent can experience moderate or severe symptoms ranging from fever, headaches and neck stiffness to neurological problems, paralysis and coma. About one in 150 people infected develop severe illness. People over the age of 50 are at the highest risk, but even healthy people can experience debilitating symptoms lasting several weeks.

There are currently no specific treatments or vaccines to combat West Nile infection, so those infected are consigned to letting the illness run its natural course.

While it is not clear who would most benefit from a West Nile vaccine, Wright suggests that it could be beneficial to certain high-risk populations, such as the elderly, people who work outside and have frequent exposure to mosquitoes, or those in specific geographic regions where West Nile cases are detected.

Finding an effective vaccine against West Nile could also open doors to developing vaccines for other insect-borne illnesses like Dengue fever, which are a priority for vaccin
'"/>




Page: 1 2

Related medicine news :

1. Researchers at Cornell University as been reported using research fund by false claims
2. A new study by John Hopkins University proposes formula for good health
3. James Cook University urges more medical seats
4. Pill splitting program of University of Michigan can save money
5. Distinguished Scientist Award Conferred on University of Rochester Scientists for Work on Preventing Cavities
6. Yale University guidelines for Physicians and Pharmaceutical industry
7. $ 1.7 Million NYSTAR Award for Binghamton University to Flex Electronics Research Muscle.
8. Florida State University declares a breathtaking study which might solve the Hepatitis C Virus maze and find a cure!
9. Hwang Woo Suk Suspended By Seoul National University
10. Vladeck to head the University of Medicine and Dentistry of New Jersey
11. Rice University wins Prestigious Grants from HHMI
Post Your Comments:
(Date:12/5/2009)Research debunks the ,something,s wrong with being single, myth , , SATURDAY, Dec. 5 (HealthDay News) -- Pity the poor single people who pass their 40th birthday without ever tying the knot, s
(Date:12/5/2009)Wind Turbines are popping up in the most unusual places, and to do everything from growing mushrooms, making wine to keeping prisoners in jail! , (PRWEB) December 5, 2009 -- W
(Date:12/4/2009)SAN FRANCISCO, Dec. 4 Medithrive, Inc. has won the Patient,s Choice Award as the favorite dispensary in the SF Bay Area by popular vote conducted by the online website, www.weedmaps.com. Despite on
(Date:12/4/2009)KANSAS CITY, Mo., Dec. 4 The large, two-day free health clinic sponsored by the National Association of Free Clinics (NAFC) in Kansas City on Wednesday and Thursday is not just for the sick but also
(Date:12/4/2009)WASHINGTON, Dec. 4 In response to the U.S. Justice Department Drug Enforcement Agency,s (DEA) classification of boldione, desoxymethyltestosterone, and 19-nor-4,9(10)-androstadienedione as "anabolic
Breaking Medicine News(10 mins):Health News:Never Married, Over 40, Well-Adjusted 2Health News:Never Married, Over 40, Well-Adjusted 3Health News:Distributor Announces New Applications for Wind Turbines 2Health News:Distributor Announces New Applications for Wind Turbines 3Health News:Free Health Clinic Event Is Not Just for the Sick 2Health News:Natural Products Association Issues Statement on DEA's Steroid Classification Action 2
...8 Eclipsys Corporation(R),(Nasdaq: ECLP ), The O...ticipating in the 10th Annual Needham Growth Stock...n New York, NY., (Logo: http://www.newscom.com/c...sted parties are invited to,listen to the presenta...
...s found eye procedure helped for at least a decade...aser surgery effectively and safely corrects sever...sts. , People with myopia, which is caused by exce...ree Americans suffers from some degree of nearsigh...
...cid boosts protein that destroys brain plaques, st...e omega-3 fatty acids found in fish oil might play...se, according to a research team at the University...fatty acid docosahexaenoic acid (DHA) increases th...
...Mich., Dec. 28 Versus,Technology, Inc. ("Versus" ... for the fiscal quarter ended October 31, 2007, co...od in 2006. Revenues for the year,ended October 31...ivery of major customer projects. Accordingly, rev...
...ponse points to ,psychological immune system, stud...News) -- When thoughts of death intrude, the human...stead, the brain instinctively moves toward happie...ved one,s death than they may have ever thought po...
...e Colonel, featured in award winning Helen Keller ... BIRMINGHAM, Ala., Dec. 28 Back in 1978, the,orig...Sanders traveled to,the Callahan Eye Foundation Ho...t and in building a then state-of-the-art,eye trea...
Other Medicine News:Health News:Eclipsys to Present at 10th Annual Needham Growth Stock Conference 2Health News:Eclipsys to Present at 10th Annual Needham Growth Stock Conference 3Health News:Laser Surgery Can Correct Nearsightedness 2Health News:Fish Oil May Help Prevent Alzheimer's 2Health News:Versus Technology Announces Fourth Quarter Results 2Health News:Versus Technology Announces Fourth Quarter Results 3Health News:Versus Technology Announces Fourth Quarter Results 4Health News:Versus Technology Announces Fourth Quarter Results 5Health News:Versus Technology Announces Fourth Quarter Results 6Health News:Versus Technology Announces Fourth Quarter Results 7Health News:Brain Turns to Positive Thoughts When Faced With Death 2Health News:Brain Turns to Positive Thoughts When Faced With Death 3Health News:Brain Turns to Positive Thoughts When Faced With Death 4Health News:Photo: KFC Colonel Original and Look-a-Like Share Eye Treatment Success Story 2Health News:Photo: KFC Colonel Original and Look-a-Like Share Eye Treatment Success Story 3
(Date:12/4/2009)MORRISTOWN, N.J., Dec. 4 Watson Pharmaceuticals, Inc. (NYSE: WPI ), a leading global specialty pharmaceutical company, today confirmed that its subsidiary, Watson Laboratories, Inc.-Florida, filed
(Date:12/4/2009)RARITAN, N.J., Dec. 4 Depression, anxiety disorder, bipolar disorder, Attention Deficit Hyperactivity Disorder (ADHD), sleep disorder and migraine: These are among the comorbidities reported to occur
(Date:12/3/2009)SUNNYVALE, Calif., Dec. 3 Pharmacyclics, Inc. (Nasdaq: PCYC ), a biopharmaceutical company focused on developing and commercializing innovative small molecule drugs for the treatment of immune media
Breaking Medicine Technology:Watson Files FDA Application for Generic Rozerem(R) 2Watson Files FDA Application for Generic Rozerem(R) 3Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 2Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 3Pharmacyclics to Host Webcast and Conference Call to Discuss Clinical Updates on Its HDAC and BTK Program as Presented at The American Society of Hematology Meeting Dec. 6 & 7 2Hospira Acquires TheraDoc Enhances Medication Safety and Infection Management Offerings 6681 1Hospira Acquires TheraDoc Enhances Medication Safety and Infection Management Offerings 6681 2Hospira Acquires TheraDoc Enhances Medication Safety and Infection Management Offerings 6681 3Hospira Acquires TheraDoc Enhances Medication Safety and Infection Management Offerings 6681 4Hospira Acquires TheraDoc Enhances Medication Safety and Infection Management Offerings 6681 5Distrust of men doesnt stall low income mothers romantic unions 62447 1Young adults who exercise get higher IQ 10960 1Young adults who exercise get higher IQ 10960 2
...BUDAPEST, Hungary and EXTON, Pa., May 26 ViroPhar...the presentation of five abstracts relating to Cin...t the 6th Annual C1 Inhibitor Deficiency Workshop....rug Administration in October 2008 for routine pro...ks in adults and adolescents. In February 2009, Vi...
...Data Confirm Tapentadol Efficacy and Tolerability ... It is estimated that up to 30 percent of all peo...ide effects, such as nausea and vomiting. The use ...is a leading risk factor for experiencing these si...and bothersome and can have an impact on a patient...
Other Medicine Technology:Scientific Data Relating to Cinryze(TM) Presented at 6th Annual C1 Inhibitor Deficiency Workshop 2Scientific Data Relating to Cinryze(TM) Presented at 6th Annual C1 Inhibitor Deficiency Workshop 3Scientific Data Relating to Cinryze(TM) Presented at 6th Annual C1 Inhibitor Deficiency Workshop 4Scientific Data Relating to Cinryze(TM) Presented at 6th Annual C1 Inhibitor Deficiency Workshop 5Scientific Data Relating to Cinryze(TM) Presented at 6th Annual C1 Inhibitor Deficiency Workshop 6Scientific Data Relating to Cinryze(TM) Presented at 6th Annual C1 Inhibitor Deficiency Workshop 7New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 2New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 3New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 4New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 5New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 6New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 7New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal 8
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
Medicine Products: